BARIATRIC SURGERY – A MODERN WAY OF CORRECTION OF REPRODUCTIVE HEALTH IN WOMEN WITH MORBID OBESITY
https://doi.org/10.17238/issn2223-2427.2019.2.21-32
Abstract
The present review is devoted to the problem of morbid obesity and reproductive disorders in women of fertile age. In fairness, we should mention the fact that the prevalence of obesity is steadily increasing worldwide. Presents recent data of literature on the prevalence, risk factors, pathogenesis and possibilities of bariatric surgery in the correction of reproductive disorders in women of fertile age.
About the Authors
I. B. Elagin
NUZ “Road Clinical Hospital named after N.A. Semashko at the Lyublino station of JSC Russian Railways
Russian Federation
Russian Federation
Elagin Ilya Borisovich - Head of the Surgery
Stavropolskaya St., dom. 23, building 1
M. R. Orazov
RUDN University
Russian Federation
Russian Federation
Orazov Mekan Rakhimberdievich – MD, Professor in the Department of obstetrics and gynecology with course of Perinatology the medical faculty, Medical Institute; the branch of specialization is obstetrics and gynecology
117198, Moscow, Miklukho - Maklaya str., h. 6
S. S. Kharnas
The I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Kharnas Sergey Saulovich – MD, professor of the Department of Faculty Surgery No. 1
119048, Moscow, st. Trubetskaya, d. 8
M. B. Khamoshina
RUDN University
Russian Federation
Russian Federation
Khamoshina Marina Borisovna - MD, professor of the Department of Obstetrics and Gynecology with a course of perinatology
st. Miklukho-Maklaya, 6, Moscow, Russia, 117198
L. R. Toktar
RUDN University
Russian Federation
Russian Federation
Toktar Liliya Ravilievna – candidate of medical sciences, associate professor of the Department of Obstetrics and Gynecology with a course of perinatology; specialization industry – obstetrics and gynecology
117198, Moscow, ul. Miklukho-Maklaya, 6
A. A. Botov
NUZ “Road Clinical Hospital named after N.A. Semashko at the Lyublino station of JSC Russian Railways
Russian Federation
Russian Federation
Botov Aleksey Andreevich – doctor-surgeon, postgraduate of the Department of general surgery, A.I. Evdokimov Moscow State University of Medicine and Dentistry
Stavropolskaya St., dom. 23, building 1
127473, Moscow, Delegatskaya St., 20/1
References
1. Aganezova N.V. Obesity and reproductive health of women. Akusherstvo and gynecology,2016, No6, рр.18-25. [In Russ].
2. Dedov I.I. The problem of obesity: from syndrome to disease. Obesity and metabolism,2006, No1(6), рр.1-4. [In Russ].
3. Dedov I.I., Melnichenko G.A. Polycystic ovary syndrome. ME Moscow,2007. [In Russ].
4. Dedov I.I., Melnichenko G.A., Shestakova M.V., Troshina E.A. et al. Treatment of morbid obesity in adults. Obesity and metabolism,2018, No15(1), рр.53-70. [In Russ].
5. Kosygina A.V. New in the pathogenesis of obesity: adipokines - hormones of adipose tissue. Problems of endocrinology,2009, No55(1), рр.4450. [In Russ].
6. Kruchinin E.V., Autlev K.M., Yanin E.L. Changes in the ovarianmenstrual cycle in patients with morbid obesity as a result of bariatric surgery // Annals of surgery. 2015.No3. C.24-8. [In Russ].
7. Kuznetsova I.V. Endometrial hyperplastic processes. M., 2009,рр. 48 . [In Russ].
8. Mychka V. B., Vertkin A. L., Vardaev L. I. et al. Expert consensus on an interdisciplinary approach to the management, diagnosis and treatment of patients with metabolic syndrome. Cardiovascular therapy and prevention, 2013,No12 (6), рр.41–81.
9. Ovsyannikova T.V., Borovkova E.I., Sheshukova N.A., Kulikov I.A. A modern view of the problem of overweight and obesity .Russian Bulletin of the Obstetrician-Gynecologist, 2010, No2 (10),рр.72-76.
10. Snegirev V.F. The place of bariatric surgery in restoring the reproductive health of an obese woman .Archives of Obstetrics and Gynecology, 2016, No3 (2) ,рр.106-107.
11. Tikanova V.V., Kuznetsova I.V. The relationship and correction of metabolic and endocrine disorders in women with menstrual irregularities against the background of obesity.Russian Journal of Obstetrics and Gynecology,2006,No6 (3), рр.12-17.
12. Tkachenko L. V., Sviridova N. I., Skladanovskaya T. V. The current state of the problem of overweight and obesity in women .Vestnik VolGMU,2017, B.4 (64),рр.3-7.
13. Fishman M. The effectiveness of laparoscopic adjustable gastric banding in women with morbid obesity and metabolic syndrome. Journal of Obstetrics and Women’s Diseases,2008,No58 (1), рр.30-35.
14. Chebotnikova T.V., Semicheva T.V. The therapeutic possibilities of metformin in the restoration of fertility in patients with polycystic ovary syndrome, literature review.Reproductive Health Bulletin. 2008, рр.13-24.
15. Chernukha G.E., M.R. Dumanovskaya. Modern views on endometrial hyperplasia (literature review) .Obstetrics and Gynecology. 2013. No3. S.26-32.
16. Abarca-Gómez L., Abdeen Z.A., Hamid Z.A., et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. The Lancet, 2017, V.390(10113),рр .2627-2642.
17. Ahluwalia, J. S., Kuo H.-C., Chang P.-C., Sun P.L., Hung K.C., Huang, C.K. Standardized Technique of Laparoscopic Adjustable Gastric Banded Plication with 4-Year Results. Obesity Surgery, 2015, V.25(9) ,рр.1756–1757.
18. Alberti K.G., Zimmet P.Z., Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet,Med, 2006, No23(5), рр.469-80.
19. Azziz R., Carmina E., Dewailly D. et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. JCE&M, 2006, V.91, рр.4237-4245.
20. Boeing H. Obesity and cancer – the update 2013. Best Pract. Res. Clin. Endocrinol. Metab.,2013, No27(2), рр.219-27.
21. Boza C., Gamboa C., Perez G., Crovari F., Escalona A., Pimentel, F. Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up. Surgical Endoscopy,2010, V.25(1), рр.292-297.
22. Budak E., Fernandez Sanchez M., Bellver J., Cervero A., Simon C., Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil. Steril.,2006, No85(6), рр.1563–81.
23. Chabrolle C., Tosca L., Rame C., Lecomte P., Royere D., Dupont J. Adiponectin increases insulin-like growth factor I – induced progesterone and estradiol secretion in human granulosa cells. Fertil. Steril.,2009, No92(6), рр.1988–96.
24. Chavarro J.E., Rich-Edwards J.W., Rosner B.A. A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur. J. Clin. Nutr.,2009, No63(1), рр.78–86.
25. Crujeiras A.B., Casanueva F.F. Obesity and the reproductive system disorders: epigenetics as a potential bridge. Hum. Reprod. Update,2014, No34(5),рр.123–36.
26. De Pergola G., Tartagni M., d’Angelo F., Centoducati C., Guida P., Giorgino R. Abdominal fat accumulation, and not insulin resistance, is associated to oligomenorrhea in nonhyperandrogenic overweight/ obese women. J. Endocrinol. Invest. ,2009, No32(2), рр.98–101.
27. Dunaif A. Insulin resistance and the PCOS: mechanism and implications for pathogenesis. Endocr Rev.,1997, V.18., рр.774-800.
28. Ed. Branca F. The challenge of obesity in the WHO European Region and the strategies for response. Repowt of WHO Regional Office for Europe. 2007 http://www.euro.who.int/document/E90711.pdf.
29. Epplein M., Reed S.D., Voight L F. et al. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am. J. Epidemiol,2008, V.168(6), рр.563-570.
30. F. Xavier Pi-Sunyer, Diane M. Becker, Claude Bouchard, Richard A. Carleton et al. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The American Journal of Clinical Nutrition,1998, 68(4), рр.899–917.
31. Freedman D.M., Ron E., Ballard-Barbash R., et al. Body mass index and all-cause mortality in a nationwide US cohort. Int. J. Obes.,2006, V.30(5), рр.822-829.
32. Fried M., Yumuk V., Oppert J.-M. et al. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery. Obesity Facts, 2013, V.6(5), рр.449-468.
33. Geliebter A., Carnell S., Gluck M.E. Cortisol and ghrelin concentrations following a cold pressor stress test in owerweight individuals with and without. Night Eating. Int. J. Obes, 2013, No37(8), рр.1104–8.
34. Gillon S., Jeanes Y. M., Andersen J. R., Våge V. Micronutrient Status in Morbidly Obese Patients Prior to Laparoscopic Sleeve Gastrectomy and Micronutrient Changes 5 years Post-surgery. Obesity Surgery, 2016, V.27(3), рр.606-612.
35. Global Health Risks: mortality and burden of disease attributable to selected major risks. Report of the World Health Organization. 2009.
36. Goodman NF. Polycystic Ovary Syndrome Writing Committee American Association of Clinical Endocrinologists position statements on metabolic and cardiovascular consequences of PCOS. Endocr Pract, 2005, V.11, . рр.126-134.
37. Guh D.P., Zhang W., Bansback N., et al. The incidence of comorbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health, 2009, V.9(1).
38. Gul O.O., Cander S., Gul B., Ackgoz E., Sarandol E., Ersoy C. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non – obese patients with polycystic ovary syndrome. Eur. Cytokine Netw, 2015, No26(4), рр.73–8.
39. Health in the European Union: Trends and Analysis. Report of the WHO European Observatory on Health Systems. 2009. Observatory Studies Series No19.
40. Heidemann C., Sun Q., van Dam R.M., Meigs J.B., Zhang C., Tworoger S.S., et al. Total and highmolecular – weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.Ann. Intern, Med. ,2008, No149(5), рр.307–16.
41. Hsueh A.J., Billig H., Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev, 1994, V.15, рр.707-724.
42. James W.F.T. Epidemiology of obesity. Internat J Obes, 1992, V.16(2), рр. 23-6.
43. Jungheim E.S., Travieso J.L., Hopeman M.M. Weighing the impact of obesity on female reproductive function and fertility. Nutr. Rev, 2013, No71, рр.3–8.
44. Kannel W.B., D’Agostino R.B., Cobb J.L. Effect of weight on cardiovascular disease. The American Journal of Clinical Nutrition,1996, V.63(3), рр.419-422.
45. Koiou E., Tziomalos K., Katsikis I., Kandaraki E.A., Kalaitzakis E., Delkos D. et al. Weight loss significantly reduces serum lipocalin – 2 levels in overweight and obese women with polycystic ovary syndrome. Gynecol. Endocrinol,2012, No28(1), рр.20–4.
46. Lars Sjöström. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med, 2013, V.273(3), рр.219-34. 50.
47. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int.,2009, V.106(40), рр.641-648.
48. Loret de Mola J.R. Obesity and its relationship to infertility in men and women. Obstet Gynecol Clin North Am.,2009, V.36(2), рр.333-346.
49. Magro D. O., Ueno M., Coelho-Neto J. de S., Callejas-Neto F., Pareja J. C., Cazzo E. Long-term weight loss outcomes after banded Rouxen-Y gastric bypass: a prospective 10-year follow-up study. Surgery for Obesity and Related Diseases, 2018, V.14(7), рр.910-917.
50. Mantzoros C.S. Leptin in relation to the lipodystrophyassociated metabolic syndrome. Diabetes Metab J., 2012 , No36(3), рр.81-9.
51. Melin I., Reynisdottir S., Berglund L., Zamfir M., Karlström B. Conservative treatment of obesity in an academic obesity unit. Long-term outcome and drop-out. Eat Weight Disord, 2006, V.11(1), рр.22-30.
52. Metwally M., Li T.C., Ledger W.L. The impact of obesity on female reproductive function. Obes. Rev, 2007, No8(6), рр.515-23.
53. Michalakis K., Mintziori G., Kaprara A. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism,2013, No62(4), рр.457-78.
54. Moran L.J., Norman R.J. The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr Clin Care,2002, V.5(6), рр.290-297.
55. Motta A.B. The role of obesity in the development of polycystic ovary syndrome. Curr. Pharm. Des, 2012, No18(17), рр.2482-91.
56. Nelson S.M., Fleming R. Obesity and reproduction: impact and interventions. Curr Opin Obstet Gynecol,2007, V.19(4), рр.384-389.
57. Nelson S.M., Flemming R.F. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod, 2007, V.22(4), рр.912-915.
58. Ogbuji Q.C. Obesity and reproductive performance in women. Afr. J. Reprod. Health,2010, No14(3), рр.143–51.
59. Rosenfield R.L., Barnes R.B., Cara J.F. Dysregulation of cytochrome P450c 17 alpha as the cause of PCOS. Fertil Steril, 1990, V.53, рр.785-791.
60. Safer DJ. Diet, behavior modification, and exercise: A review of obesity treatments from a long–term perspective. South Med J.,1991, V.84.
61. Salley K.E., Wickham E.P., Cheang K.I. Position Statement: Glucose intolerance in polycystic ovary syndrome a position statement of the Androgen Excess Society. JCE&M. 2007, V.92, рр.4546-4556.
62. Shekelle PG, Newberry S, Maglione M, Li Z, Yermilov I et. al. Bariatric surgery in women of reproductive age: special concerns for pregnancy. Evid Rep Technol Assess,2008, V.169, рр.1-51.
63. Skov V., Glintborg D., Knudsen S. Reduced expression of nuclearencoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with PCOS. Diabetes, 2007, V.56,рр.2349-2355.
64. Skubleny D, Switzer NJ, Gill RS, et al. The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Surg, 2016, V.26(1), рр.169-76.
65. Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr. Regul,2010, No44(1), рр.25–36.
66. Sturm R. Increases in clinically severe obesity in the United States, 1986– 2000. Arch Intern Med, 2003, No163(18), рр.2146-2148.
67. Velazquez E.M., Mendoza S., Hamer T. Metformin therapy in PCOS reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabol, 1994, V.43, рр.647-654.
68. Volkan Yumuk et. al. European Guidelines for Obesity Management in Adults. Obes Facts,2015, V.8,рр.402–424
69. Wang Y., Beydoun M. A., Liang L. et al. Will all americans become overweight or obese. Estimating the progression and cost of the US obesity epidemic. Obesity, 2008, No16(10), рр.2323-2330.
70. Weng T.-C., Chang C.-H., Dong Y.-H., Chang Y.-C., Chuang L.-M. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open, 2015, V.5(7).
Review
For citations:
Elagin I.B., Orazov M.R., Kharnas S.S., Khamoshina M.B., Toktar L.R., Botov A.A. BARIATRIC SURGERY – A MODERN WAY OF CORRECTION OF REPRODUCTIVE HEALTH IN WOMEN WITH MORBID OBESITY. Surgical practice (Russia). 2019;(2):21-32. (In Russ.) https://doi.org/10.17238/issn2223-2427.2019.2.21-32
Views:
598
Email this article 